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Abstract The effect of the expression of murine Bax protein on
growth and vitality was examined in Saccharomyces cerevisiae
and compared with the effect of Bax in mutant cells lacking
functional mitochondria. The cytotoxic effect of Bax on yeast
does not require functional oxidative phosphorylation, respira-
tion, or mitochondrial proteins (ADP/ATP carriers) implicated
in the formation of the permeability transition pore in
mammalian mitochondria. In the wild type S. cerevisiae the
expression of Bax does not result in a severe effect on
mitochondrial membrane potential and respiration. On the basis
of Bax induced differences in the fluorescence of green
fluorescent protein fused to mitochondrial proteins, it is proposed
that Bax may interfere with one essential cellular process in
yeast: the mitochondrial protein import pathway that is specific
for the proteins of the mitochondrial carrier family.
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1. Introduction
The ¢nding that the proteins encoded by the genes of the
Bcl-2 family interfere with the growth of yeast cells [1^3] has
initiated the use of this organism as a tool for investigating
the mechanism of action of proteins involved in the metazoan
apoptosis. One important aspect of this mechanism is the
participation of mitochondria in cell death [4,5]. Mitochon-
dria have been shown to play a key function in the decisive
phase of metazoan apoptosis, in which the interaction be-
tween mitochondrial membranes and proapoptotic proteins
(e.g. Bax and Bak) leads to a release of proteins, such as
cytochrome c and apoptosis-inducing factor (AIF) from mi-
tochondria to the cytosol [6^9]. These events are prevented by
anti-apoptotic members of the Bcl-2 family of proteins
[7,8,10]. Upon entering the cytosol, cytochrome c forms a
complex with Apaf1, a homologue of the Caenorhabditis ele-
gans protein ced-4, and caspase 9, which further triggers cas-
pase activation and cell death [11].
The release of proteins from mammalian mitochondria
probably results from the opening of an unspeci¢c mitochon-
drial channel termed permeability transition pore (PTP) and
this event is either preceded, or accompanied by loss of mi-
tochondrial transmembrane potential (v8) [7,8,12,13]. It has
been proposed that PTP is a complex of several proteins in-
cluding inner membrane ADP/ATP carrier (AAC), the outer
membrane voltage-dependent anion channel (VDAC), and the
matrix cyclophilin D [6,14]. The central role of AAC in PTP
and apoptosis is supported by observations that some forms
of apoptosis are suppressed by a speci¢c ligand of AAC,
bongkrekic acid, that inhibits both mitochondrial ADP/ATP
transport and PTP opening [12,15,16]. Evidence was recently
presented that Bax and AAC cooperate within PTP [17,18] to
increase mitochondrial permeability and to trigger cell death.
The failure of Bax to kill AAC-less yeast strain was inter-
preted to indicate that Bax and AAC cooperate in the mito-
chondrial control of apoptosis [17].
The goal of understanding the mechanisms that trigger cell
death would be facilitated by being able to assess the function
of apoptosis-regulating proteins in unicellular eukaryotes that
are easily amenable to genetic manipulations. Similar to mam-
malian cells undergoing apoptosis, yeast cells expressing Bax
exhibit mitochondrial localization of the latter, cytochrome c
release to the cytosol [19,20], and apoptotic phenotype [21]
that are prevented by co-expression of anti-apoptotic protein
Bcl-xL [1,2,22]. Yet, mutants of Bcl-xL, which retain the abil-
ity to bind Bax but which are de¢cient in anti-apoptotic ac-
tivity in mammalian cells, are similarly unable to suppress
Bax-induced e¡ects in yeast [2]. These observations indicate
that in yeast cells Bax may act directly upon conserved cellu-
lar components that correspond to their apoptotic targets in
mammalian cells.
In this work, the e¡ects of Bax expression on Saccharomy-
ces cerevisiae cells were reexamined using mutants and phys-
iological conditions that altered mitochondrial oxidative phos-
phorylation and mitochondrial biogenesis. In contrast to the
results obtained by other investigators [17,22,23] our results
demonstrate that neither fully active mitochondria, nor pres-
ence of AAC protein in mitochondrial membrane are required
for Bax-induced growth defects in yeast cells. In addition, our
results suggest that in S. cerevisiae Bax may intrude upon one
essential cellular pathway involving targeting and import of
proteins to the mitochondria.
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2. Materials and methods
2.1. Yeast strains, plasmids and growth conditions
The wild type strain W303-1B (MATK, ade2, leu2, his3, trp1, ura3,
can1) provided by B.L. Trumpower (Dartmouth Medical School,
Hanover, NH, USA) was used for preparation of the mutants listed
below; the AAC2 disrupted strain JLY-73 (MATK, ade2, leu2, his3,
trp1, ura3, can1, aac2: :HIS3), the triple aac mutant JL-1-3 (MATK,
ade2, leu2, his3, trp1, ura3, can1, aac1: :LEU2, aac2: :HIS3, aa-
c3: :URA3), and the mitochondrial respiratory de¢cient (b0) mutant
prepared by ethidium bromide mutagenesis.
The cDNA for mouse bax gene was cloned in YEp51 [19] and
YpN2 [24] for Gal-promoter regulated expression of Bax in yeast.
The shuttle vector pRS314 containing the bovine AAC gene, in which
the region encoding N-terminal 13 amino acids of the bovine gene was
substituted for the corresponding region of yeast AAC2 gene [25], was
used to express the hybrid yeast bovine protein in AAC2 deleted
(JLY-73) strain.
The plasmid pGFP-C-FUS-AAC1 containing the whole AAC1
open reading frame (lacking stop codon) fused with green £uorescent
protein (GFP) was prepared by ligation of PCR product ampli¢ed
with 5P-CGGGATCCATGTCTCACACAGAAACA-3P and 5P-CGG-
AATTCCTTGAATTTTTTGCC-3P primers, into BamHI, EcoRI-di-
gested pGFP-C-FUS vector ([26], provided by J.H. Hegemann, Jus-
tus-Liebig University, Giessen, Germany). The construction of pGFP-
C-FUS-mitochondrial telomere binding protein (MTP1) plasmid con-
taining the MTP1 reading frame is described in [27].
Yeast cells transformed with control (YEp51, YpN2) and Bax con-
taining (YEp-Bax, YpN2-Bax) vectors were inoculated into synthetic
liquid medium (SM, 0.67% yeast nitrogen base, Difco) supplemented
with indicated carbon source and nutritional requirements, and grown
until exponential growth phase. To induce Bax expression, the cells
were harvested, washed twice with sterile water, diluted to 106 cells/ml
into fresh minimal medium containing 2% galactose, and grown either
aerobically at 30‡C, or anaerobically as described before [24]. The
plating e⁄ciency (clonogenicity) of Bax-expressing and control-plas-
mid containing cells was estimated by aliquots taken out at di¡erent
times after induction and plating 500 cells on solid 2% agar containing
minimal (SM) or complex (YP) medium containing 1% yeast extract,
2% Bacto peptone (Difco), and supplemented with 2% glucose. The
number of colonies was scored after 2^3 days of growth at 30‡C.
2.2. Mitochondrial v8 assay, oxygen consumption, and GFP
£uorescence
Yeast spheroplasts, prepared as in [28], were resuspended at con-
centration 1 mg protein/ml in a medium containing 1 M sorbitol, 0.5
mM EGTA, 2 mM MgSO4, 1.7 mM NaCl, 10 mM potassium phos-
phate, 0.1% bovine serum albumin, pH 6.8 and permeabilized with 20
Wg/ml nystatin (Sigma) for 10 min at 28‡C as described in [29]. The
mitochondrial transmembrane potential (v8) was estimated in the
permeabilized spheroplasts with rhodamine 123 (Molecular Probes)
using a Shimadzu RF-5301PC spectro£uorimeter at 507 and 529 nm
excitation and emission wavelengths, respectively. The oxygen con-
sumption by permeabilized spheroplasts was measured using a Clark
oxygen electrode in the same medium as described above.
Cells transformed with the GFP fusion containing plasmids were
loaded with 4P,6-diamidino-2-phenyl-indole (DAPI, Molecular
Probes) and observed at the indicated times using a Olympus BX-50
£uorescence microscope equipped with ¢lters recommended by the
manufacturer.
2.3. DNA manipulations and analysis
DNA isolations, labeling, cloning, sequencing, Northern blotting,
and hybridization were performed essentially as described in [30]. The
lithium acetate procedure was used for yeast transformations [31]. The
enzymes for DNA manipulations, DNA labeling, and radiochemicals
were purchased from Amersham Pharmacia Biotech.
3. Results
3.1. Bax induced inhibition of growth and clonogenicity of yeast
cells
We focused on studying the e¡ects of Bax in mitochondrial
mutants of S. cerevisiae since previous studies have demon-
strated an essential role of these organelles in mammalian
apoptosis [5^9]. For this purpose yeast expression vectors con-
taining Bax gene under Gal promoters were transformed into
the wild type strain, as well as into the mutants strains with
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defects in mitochondrial oxidative phosphorylation. The latter
included a respiratory de¢cient (b0) mutant, two nuclear mu-
tants in which either the major AAC2 gene, or all three
(AAC1, AAC2, AAC3) AAC encoding genes were deleted,
and the AAC-less strain expressing a recombinant bovine
ANT2 (adenine nucleotide translocator) gene [25]. As shown
in Fig. 1, the induction of Bax expression, by shifting the
carbon source in the medium from glucose to galactose, re-
sulted in unequal inhibition of growth yields and unequal
increase of duplication time in wild type and mutant strains.
Bax expressing wild type and mutant cells were not capable of
recovering growth when plated on glucose containing SM.
Inhibition of growth and plating e⁄ciency were also observed
in the mutant expressing recombinant bovine ANT gene (Fig.
1), as well as in the wild type strain grown under anaerobic
conditions (not shown).
As the growth rate and the extent of Bax induced growth
inhibition in di¡erent mutants varied, we evaluated the cyto-
toxic e¡ect of Bax in relation to the number of cell divisions
(Fig. 2). This demonstrates that in all tested strains 2^3 cell
divisions in the presence of Bax are su⁄cient to achieve 90%
decrease of plating e⁄ciency at conditions requiring the plas-
mid maintenance (SM-2% glucose).
We concluded that mouse Bax gene inhibited the growth
and plating e⁄ciency of wild type and mutant yeast strains
independently of the presence, or the absence of functional
oxidative phosphorylation and/or AAC proteins in their mi-
tochondria. As both cell division and Bax expression in ga-
lactose containing media depend on Gal promoter, it is con-
ceivable that the di¡erent e¡ect of Bax on the growth of
mutant cells is due to the di¡erent strength of the promoter
under di¡erent physiological conditions.
3.2. The expression of Bax in S. cerevisiae inhibits
mitochondrial respiration but does not dissipate the
mitochondrial transmembrane potential (v8)
Northern blot analysis indicates that the wild type cells
transformed with YEp-Bax express a high level of Bax
mRNA in a short time after galactose induction (Fig. 3).
Therefore, to estimate the early e¡ects of Bax on the mito-
chondrial functions, the cells were harvested 6 h after Bax
induction, converted to spheroplasts, and permeabilized with
nystatin [29]. The latter treatment enabled the measurements
of mitochondrial membrane potential and respiration without
puri¢cation procedures that could eventually eliminate a part
of the organelle’s population a¡ected by Bax. As shown in
Fig. 4a, the mitochondria in Bax expressing cells were capable
of developing mitochondrial transmembrane potential (v8)
with a magnitude similar to that observed in the control cells.
In contrast to the latter, however, the addition of ADP to
mitochondria in Bax expressing cells does not produce a de-
crease of v8. The drop of v8 in the control cells probably
re£ects its consumption during ADP transport and phosphor-
ylation. Additions of either oligomycin, or atractylate to the
control protoplasts (not shown) can mimic the e¡ect of Bax
expression indicating that Bax a¡ects the oxidative phosphor-
ylation of yeast mitochondria. This is further substantiated by
assessment of the respiration rates of nystatin treated spher-
oplasts (Fig. 4b). The oxygen consumption of spheroplasts
prepared from Bax-expressing cells proceeds with a maximal
rate in the absence of ADP and uncoupler. It represents only
50% of the maximal respiration rate of cells transformed with
the control plasmid. The diminished respiration rate is in
agreement with the reduced content of cytochrome c oxidase
observed in Bax expressing cells [20]. The features of mito-
chondria in Bax expressing yeast cells thus con¢rm that Bax
protein interacts with mitochondrial membranes and a¡ects
the mitochondrial function.
3.3. The estimation of possible Bax e¡ect on the mitochondrial
protein import
Taking into account that mitochondrial biogenesis in yeast
cells is an essential process, we have investigated the e¡ect of
Fig. 2. Relationship between plating e⁄ciency and number of cell
divisions in the presence of Bax. Wild type transformed with the
control plasmid (-a-). The wild type (-b-), the respiratory de¢cient
(b0) mutant (-R-), the AAC2 deletion mutant (-S-), the triple aac
deleted strain (-8-), and the strain expressing the hybrid AAC-ANT
gene (-F-) transformed with Bax containing plasmid.
Fig. 1. Bax-induced inhibition of growth (upper panel) and plating
e⁄ciency (lower panel) of S. cerevisiae cells. (a) The wild type, (b) a
respiratory de¢cient (b0) mutant, (c) the AAC2 deletion mutant
(JLY-73), (d) the triple aac deleted strain (JL-1-3), and (e) the JLY-
73 mutant expressing the hybrid yeastPbovine AAC-ANT gene were
transformed with the control (open circles) and Bax containing (full
circles) vectors and grown into 2% galactose containing SM medium
as described in Section 2. The plating e⁄ciency (lower panel) was
evaluated at di¡erent times after Bax induction. Aliquots of the cul-
tures were taken out, washed with sterile water and plated on a
minimal 2% glucose containing solid medium. The number of colo-
nies was scored after 2^3 days of growth at 30‡C.
6
Fig. 3. Northern blot analysis of the Bax mRNA levels. The total
RNA from the wild type strain transformed with YEp-Bax was iso-
lated at the indicated time after galactose induction. The RNA (10
Wg) was denatured, electrophoresed, blotted and probed as described
[24] with a 32P-labelled fragment from the murine Bax gene.
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Bax on the import of protein to the mitochondria. For this
purpose we have used GFP fusions with two mitochondrial
proteins ^ the MTP1 that contains a cleavable N-terminal
targeting sequence [27], and the AAC1 that belongs to the
mitochondrial carrier family of proteins possessing internal
targeting sequences and taken up by mitochondria by a di¡er-
ent import pathway [32,33]. To estimate the e¡ect of Bax on
the import of these two kinds of fusion proteins, the cells were
co-transformed with Bax carrying plasmids, cultured on SD-
Gal medium to induce Bax expression, and analyzed for £uo-
rescence at di¡erent time intervals. Both MTP1^GFP and
AAC1^GFP fusion proteins localize to the mitochondria as
demonstrated by DAPI staining of mtDNA (Fig. 5B,C,BP,CP).
The induction of Bax resulted in the appearance of green^
yellow £uorescent cells that are also homogeneously stained
by DAPI (Fig. 5E^I, EP^IP). As such cells were rarely seen in
the control vector (YEp51) containing culture (Fig. 5KP,LP)
and were also stained by methylene blue (data not shown),
they probably represent the non-viable cell population as a
consequence of Bax action. The number of these cells in-
creases with the time after Bax induction, but it remains
roughly equal in both MTP1^GFP and AAC1^GFP contain-
ing cells.
In addition, the inspection of Bax e¡ect on GFP £uores-
cence provided dissimilar pictures originating from both
MTP1^GFP and AAC1^GFP fusions. Almost all viable cells
co-expressing Bax and MTP1^GFP for 24 and 48 h (Fig.
5E,H) exhibited an intensive mitochondrial £uorescence. At
the same time, the number of cells with visible mitochondrial
£uorescence, co-expressing Bax and AAC1^GFP, was mark-
edly diminished (Fig. 5EP,HP). In the control cells that do not
express Bax, the £uorescence yielded by AAC1^GFP re-
mained basically unchanged (Fig. 5KP). These observations
suggest that either the AAC1^GFP fusion is faster and specif-
ically degraded by the cellular proteases in Bax expressing
cells, or the import of mitochondrial carrier proteins is pref-
erentially a¡ected by Bax as compared to the import of pro-
teins containing an N-terminal targeting sequence.
4. Discussion
Although no obvious homologues of any important regu-
lator of metazoan apoptosis in the S. cerevisiae genome were
detected, the expression of the latter two classes of proteins
induces growth defects and cellular phenotypes characteristic
for metazoan apoptotic cells [19^23]. It was suggested that the
cytotoxic e¡ects of Bax in yeast cells are relevant to its mech-
anism of action in mammalian cells and that it most probably
involves mitochondria as a target for proapoptotic protein
action. The results presented in this study con¢rm and extend
the previous published observations that expression of Bax in
yeast inhibited the cell divisions and a¡ected the mitochon-
drial functions in this organism [20^23]. In addition, we
showed that the e¡ect of Bax on S. cerevisiae does not require
mitochondrial functions associated with the oxidative phos-
phorylation. This is demonstrated here by the experiments
showing that (i) the wild type respiratory competent cells,
(ii) the respiratory de¢cient (b0) mutant lacking mitochondrial
DNA, (iii) AAC-less mutants lacking AAC proteins in inner
mitochondrial membrane, and (iv) anaerobically-grown wild
type cells, were all a¡ected by Bax in a similar manner. In
addition, our results demonstrate that the interaction between
mammalian AAC and Bax protein, previously demonstrated
by the two-hybrid assay and co-immunoprecipitation [17], has
not substantially changed the cytotoxic e¡ect of Bax in yeast
cells. These observations contradict the ¢ndings published by
others that fully active mitochondria [22,23], or mitochondrial
AAC [17] are essential for Bax induced cytotoxicity in yeast.
The discrepancies between the latter works and these pre-
sented here are probably due to the fact, that the enzymes
involved in galactose metabolism are repressed in cells with
impaired mitochondrial functions and consequently Gal pro-
moter does not function properly in these cells. Recent work
[34] using a tetracycline inducible promoter to express Bax in
the AAC-less mutant has indeed shown that the absence of
AAC did not modify Bax-induced lethality.
The e¡ect of Bax on both the mitochondrial respiration and
Fig. 4. The expression of Bax a¡ects mitochondrial functions in yeast cells. The wild type cells transformed with either YEp-Bax, or YEp51
plasmids were harvested 6 h after galactose induction, converted to spheroplasts by enzymatic digestion as described in [28], and treated with
nystatin to permeabilize the cell plasma membrane. a: The changes of mitochondrial v8 were assessed by following rhodamine 123 £uorescence
as described in Section 2. b: The respiration rates of permeabilized spheroplast were measured by a Clark oxygen electrode.
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the properties of mitochondrial transmembrane potential (Fig.
4) indicates that Bax interacts with the yeast mitochondrial
proteins and/or lipids. The pleiotropic e¡ect of this interaction
also include cytochrome c release from the intermembrane
space of yeast [20] and mammalian mitochondria [7,8], indi-
cating that outer mitochondrial membrane belongs among the
Bax targets in both type of cells. The question is, however,
how could the impaired mitochondrial functions account for
the cytotoxic e¡ect of Bax on yeast cells?
S. cerevisiae are facultative anaerobes and can easily survive
mitochondrial defects as these described above. In yeast, mi-
tochondria can a¡ect the cell division by one of the following
two pathways; ¢rst, by simultaneous inhibition of both ADP/
ATP transport and respiration that leads to depletion of the
intra-mitochondrial ATP pool [35] and second, by mutations
of mitochondrial proteins participating in the import of pro-
teins to the mitochondria (for review see [36]). The intra-mi-
tochondrial ATP pool and protein import machinery are both
required for mitochondrial biogenesis and they are the only so
far known essential mitochondrial constituents. Therefore,
they might represent attractive targets for the execution of
mitochondrial control in cell death. Our experiments in which
we followed the mitochondrial £uorescence yielded from two
mitochondrial proteins fused to GFP provide support for Bax
action on the mitochondrial protein import process. The fast-
er extinguishing of mitochondrial AAC1^GFP £uorescence in
larger number of Bax expressing cells, as compared to the
extinction of MTP1^GFP, suggests that Bax preferentially
inhibits the import of carrier proteins to yeast mitochondria.
Although, other explanations might be also o¡ered (e.g. dif-
ferent susceptibility of the recombinant proteins to cellular
proteases), our presumption that Bax may a¡ect preferentially
the import of carrier proteins can ¢nd support in other ex-
perimental results. It is known in yeast and mammalian cells
that Bax increases the permeability of outer mitochondrial
membrane and release proteins that are located at the inter-
membrane space of mitochondria [7,8,20,37]. At the same
time in vitro experiments with isolated yeast mitochondria
demonstrated that intact outer membrane is essential for the
import of carrier proteins, but not for the import of N-termi-
nal targeting sequence containing proteins [38]. Thus Bax in-
duced permeabilization of outer mitochondrial membrane in
vivo might have a similar e¡ect on the import of carrier pro-
teins to yeast mitochondria. One can hypothesize further that
the inhibition of the import can be executed by one of the two
alternative ways. First, by Bax induced permeability of outer
mitochondrial membrane and release of essential soluble com-
ponents (TIM9, TIM10, TIM12, TIM8) of import machinery
[32,33,36,38]. The second possibility might be that Bax simply
compete and preferentially occupy the protein import machi-
nery that is speci¢c for mitochondrial carrier proteins. The
work to test these possibilities is now in progress in our labo-
ratory. Whatever the mechanism underlying Bax e¡ect on the
mitochondrial carrier proteins import, it provides a link be-
tween the two observed Bax induced phenomena ^ the mito-
chondrial defects and the growth inhibition of yeast cells.
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